Nov Inc (NOV)

$13.84 -0.24 (-1.70%)
Market Cap 5.23B
Revenue (ttm) 8.87B
Net Income (ttm) 635.00M
EPS (ttm) N/A
PE Ratio 10.90
Forward PE 13.73
Profit Margin 7.16%
Debt to Equity Ratio 0.26
Volume 4,026,800
Avg Vol 3,487,034
Day's Range N/A - N/A
Shares Out 371.37M
Stochastic %K 80%
Beta 1.26
Analysts Sell
Price Target $15.00

Company Profile

NOV Inc. designs, constructs, manufactures, and sells systems, components, and products for oil and gas drilling and production, and industrial and renewable energy sectors in the United States and internationally. It operates through two segments, Energy Equipment, and Energy Products and Services. The Energy Equipment segment offers equipment and systems, spare parts, repair, and rentals; hydration units, chemical additive systems, blenders, and control systems, as well as centrifugal pumps, v...

Industry: Oil & Gas Equipment & Services
Sector: Energy
Phone: 346 223 3000
Website: www.nov.com
Address:
10353 Richmond Avenue, Houston, United States
HeidiNorris9100
HeidiNorris9100 Oct. 23 at 9:01 PM
High-conviction cluster — risk-defined entries only! Portfolio: $META $NOV $BF.B $OXY $ZM Why this cluster: Sector strength aligning with positive sentiment; disciplined entries and stops recommended. META shows relative strength; NOV is base-building; BF.B is a stealth accumulator; OXY offers sector exposure; ZM provides stability. Execution: Plan: small starter position, scale with a confirmed trend; respect risk. #RiskManaged #TopPicks Source:https://stocktwits.com/GaryBrown7417/message/632828520
0 · Reply
RodneyOwens7668
RodneyOwens7668 Oct. 23 at 7:28 PM
High-conviction cluster — risk-defined entries only! Portfolio: $XOM $NVDA $MRK $NOV $LLY Why this cluster: Accumulation noted, range tightening, and cross-sector flow suggests rotation into these names. XOM shows relative strength; NVDA is base-building; MRK is a stealth accumulator; NOV offers sector exposure; LLY provides stability. Execution: Plan: small starter position, scale with a confirmed trend; respect risk. #TradeSetup #Watchlist Source:https://stocktwits.com/VeronicaWarren8662/message/632828887
0 · Reply
Nosecandy_Bear
Nosecandy_Bear Oct. 23 at 6:01 PM
$COST $FDX $NOV $RIVN $T
0 · Reply
ZoeCordova1371
ZoeCordova1371 Oct. 23 at 4:54 PM
Hot setup alert — potential multi-leg move incoming! Portfolio: $LOW $TMUS $AMD $NOV $ORCL Why this cluster: Clean technical bases with improving relative strength; catalysts may trigger a rapid move. LOW shows relative strength; TMUS is base-building; AMD is a stealth accumulator; NOV offers sector exposure; ORCL provides stability. Execution: Watch: monitor news flow and intraday volume for confirmation before heavy sizing. #RiskManaged #TopPicks Source: https://stocktwits.com/GloriaCabrera2156/message/632828656
0 · Reply
CynthiaShepherd1804
CynthiaShepherd1804 Oct. 23 at 4:33 PM
Tape is smoking — catalysts near, volume rising! Portfolio: $NOV $T $FDX $RIVN $COST Why this cluster: Accumulation noted, range tightening, and cross-sector flow suggests rotation into these names. NOV shows relative strength; T is base-building; FDX is a stealth accumulator; RIVN offers sector exposure; COST provides stability. Execution: Execution: define stop levels, use partial profit-taking on initial leg. #MarketPulse #Technical Source: https://stocktwits.com/BrianWatson9291/message/632825018
1 · Reply
ZacksResearch
ZacksResearch Oct. 21 at 6:30 PM
$NOV earnings on deck — and expectations aren’t looking great. Revenue and profit forecasts are signaling declines as softer drilling demand pressures the outlook. Full pre-earnings breakdown here 👉 https://www.zacks.com/stock/news/2773412/factors-you-need-to-know-ahead-of-novs-q3-earnings-release?cid=sm-stocktwits-2-2773412-teaser-16993&ADID=SYND_STOCKTWITS_TWEET_2_2773412_TEASER_16993
0 · Reply
ZacksResearch
ZacksResearch Oct. 21 at 5:30 PM
$NOV Q3 2025 earnings preview — will it disappoint again? 🤔 ⚠️ Expected 27.3% YoY EPS decline for Q3 2025 📉 Revenue forecasted to drop 2.4% from the year-ago period 🛢️ Slowdown in global drilling activity Full analysis here 👉 https://www.zacks.com/stock/news/2773412/factors-you-need-to-know-ahead-of-novs-q3-earnings-release?cid=sm-stocktwits-2-2773412-body-16980&ADID=SYND_STOCKTWITS_TWEET_2_2773412_BODY_16980
0 · Reply
mktxogzqw
mktxogzqw Oct. 18 at 5:18 AM
?? Hot setup alert — potential multi-leg move incoming! ???? ?? Portfolio: $VZ $NOV $IBM $DUK $CAT ?? Why this cluster: Sector strength aligning with positive sentiment; disciplined entries and stops recommended. VZ shows relative strength; NOV is base-building; IBM is a stealth accumulator; DUK offers sector exposure; CAT provides stability. ?? Execution: Watch: monitor news flow and intraday volume for confirmation before heavy sizing. ?? ???? #RiskManaged #TopPicks ???? ?? Source: https://stocktwits.com/RachelWilkerson7204/message/632828552
0 · Reply
DividendDaddyDK
DividendDaddyDK Oct. 16 at 11:11 PM
$NOV are you talking to the man in the mirror?
1 · Reply
ianvestor
ianvestor Oct. 16 at 10:47 PM
$NOV The CEO stepped down 5 months ago you fucking clown.
0 · Reply
Latest News on NOV
These 3 Beaten-Down Oil Stocks Could Make A Big Comeback

Oct 15, 2025, 8:18 AM EDT - 10 days ago

These 3 Beaten-Down Oil Stocks Could Make A Big Comeback

NOA RNGR

NOV Announces Third Quarter 2025 Earnings Conference Call

Sep 29, 2025, 6:30 AM EDT - 26 days ago

NOV Announces Third Quarter 2025 Earnings Conference Call

NOV Declares Regular Quarterly Dividend

Aug 14, 2025, 6:30 AM EDT - 2 months ago

NOV Declares Regular Quarterly Dividend

NOV Inc. (NOV) Q2 2025 Earnings Conference Call Transcript

Jul 29, 2025, 5:08 PM EDT - 3 months ago

NOV Inc. (NOV) Q2 2025 Earnings Conference Call Transcript

NOV Reports Second Quarter 2025 Results

Jul 28, 2025, 5:45 PM EDT - 3 months ago

NOV Reports Second Quarter 2025 Results

NOV: Growth Proposition Intact Despite Near-Term Headwind

Jul 9, 2025, 12:47 AM EDT - 3 months ago

NOV: Growth Proposition Intact Despite Near-Term Headwind

NOV Announces Second Quarter 2025 Earnings Conference Call

Jun 27, 2025, 6:30 AM EDT - 4 months ago

NOV Announces Second Quarter 2025 Earnings Conference Call

NOV Declares Regular Quarterly Dividend and Supplemental Dividend

May 21, 2025, 6:30 AM EDT - 5 months ago

NOV Declares Regular Quarterly Dividend and Supplemental Dividend

NOV Inc. (NOV) Q1 2025 Earnings Call Transcript

Apr 29, 2025, 12:44 PM EDT - 6 months ago

NOV Inc. (NOV) Q1 2025 Earnings Call Transcript

NOV Reports First Quarter 2025 Results

Apr 28, 2025, 5:45 PM EDT - 6 months ago

NOV Reports First Quarter 2025 Results

NOV Announces Key Leadership Changes

Mar 19, 2025, 5:00 PM EDT - 7 months ago

NOV Announces Key Leadership Changes

NOV: Shareholder Returns Have Likely Peaked For Now

Feb 7, 2025, 3:21 PM EST - 9 months ago

NOV: Shareholder Returns Have Likely Peaked For Now

NOV Inc. (NOV) Q4 2024 Earnings Call Transcript

Feb 5, 2025, 3:12 PM EST - 9 months ago

NOV Inc. (NOV) Q4 2024 Earnings Call Transcript

NOV Reports Fourth Quarter and Full-Year 2024 Earnings

Feb 4, 2025, 5:45 PM EST - 9 months ago

NOV Reports Fourth Quarter and Full-Year 2024 Earnings

NOV Announces Fourth Quarter and Full Year 2024 Earnings Conference Call

Dec 23, 2024, 6:30 AM EST - 10 months ago

NOV Announces Fourth Quarter and Full Year 2024 Earnings Conference Call

NOV Appoints Chris Kendall to the Board of Directors

Dec 16, 2024, 6:30 AM EST - 11 months ago

NOV Appoints Chris Kendall to the Board of Directors

The Big 3: DJT, JD, NOV

Dec 5, 2024, 12:27 PM EST - 11 months ago

The Big 3: DJT, JD, NOV

DJT JD

Venture Builder VC Launches NOV Supernova Accelerator to Drive Digital Transformation in Upstream Oil & Gas with Disruptive Startups

Nov 12, 2024, 2:11 PM EST - 1 year ago

Venture Builder VC Launches NOV Supernova Accelerator to Drive Digital Transformation in Upstream Oil & Gas with Disruptive Startups

These Analysts Lower Their Forecasts On NOV Following Q3 Results

Oct 28, 2024, 11:06 AM EDT - 1 year ago

These Analysts Lower Their Forecasts On NOV Following Q3 Results

NOV Inc. (NOV) Q3 2024 Earnings Call Transcript

Oct 25, 2024, 2:55 PM EDT - 1 year ago

NOV Inc. (NOV) Q3 2024 Earnings Call Transcript

NOV Reports Third Quarter 2024 Results

Oct 24, 2024, 5:45 PM EDT - 1 year ago

NOV Reports Third Quarter 2024 Results

14 energy stocks whose ample cash flow might benefit shareholders

Sep 30, 2024, 11:11 AM EDT - 1 year ago

14 energy stocks whose ample cash flow might benefit shareholders

BTU CHRD COP DVN FANG HAL LBRT

NOV Announces Third Quarter 2024 Earnings Conference Call

Sep 23, 2024, 6:30 AM EDT - 1 year ago

NOV Announces Third Quarter 2024 Earnings Conference Call

NOV Inc. (NOV) Q2 2024 Earnings Call Transcript

Jul 26, 2024, 3:27 PM EDT - 1 year ago

NOV Inc. (NOV) Q2 2024 Earnings Call Transcript

NOV Reports Second Quarter 2024 Results

Jul 25, 2024, 6:00 PM EDT - 1 year ago

NOV Reports Second Quarter 2024 Results

6 Stocks That Have Come Too Far, Too Fast

Jul 22, 2024, 11:23 AM EDT - 1 year ago

6 Stocks That Have Come Too Far, Too Fast

BJRI COOP CUBI MXL SAH

NOV: A Top Oil And Gas Services Pick Under Quiet Accumulation

Jul 9, 2024, 5:28 PM EDT - 1 year ago

NOV: A Top Oil And Gas Services Pick Under Quiet Accumulation

NOV Announces Second Quarter 2024 Earnings Conference Call

Jun 21, 2024, 6:30 AM EDT - 1 year ago

NOV Announces Second Quarter 2024 Earnings Conference Call

NOV Announces 50 Percent Increase in Regular Quarterly Dividend

May 16, 2024, 6:30 AM EDT - 1 year ago

NOV Announces 50 Percent Increase in Regular Quarterly Dividend

NOV Inc. (NOV) Q1 2024 Earnings Call Transcript

Apr 26, 2024, 3:50 PM EDT - 1 year ago

NOV Inc. (NOV) Q1 2024 Earnings Call Transcript

NOV Reports First Quarter 2024 Results, Return of Capital Framework, $1 Billion Share Repurchase Authorization, and Plan to Increase Dividend 50%

Apr 25, 2024, 6:09 PM EDT - 1 year ago

NOV Reports First Quarter 2024 Results, Return of Capital Framework, $1 Billion Share Repurchase Authorization, and Plan to Increase Dividend 50%

Bullish on NOV

Apr 15, 2024, 1:14 PM EDT - 1 year ago

Bullish on NOV

Arcosa, Inc. Announces Completion of Ameron Acquisition

Apr 9, 2024, 4:15 PM EDT - 1 year ago

Arcosa, Inc. Announces Completion of Ameron Acquisition

ACA

NOV Announces First Quarter 2024 Earnings Conference Call

Mar 26, 2024, 6:30 AM EDT - 1 year ago

NOV Announces First Quarter 2024 Earnings Conference Call

Arcosa Announces Agreement to Acquire Ameron Pole Products from NOV Inc.

Mar 11, 2024, 8:00 AM EDT - 1 year ago

Arcosa Announces Agreement to Acquire Ameron Pole Products from NOV Inc.

ACA

NOV Announces Opening of Regional Headquarters in Dammam, Saudi Arabia

Feb 22, 2024, 4:34 PM EST - 1 year ago

NOV Announces Opening of Regional Headquarters in Dammam, Saudi Arabia

NOV Inc. (NOV) Q4 2023 Earnings Call Transcript

Feb 2, 2024, 1:58 PM EST - 1 year ago

NOV Inc. (NOV) Q4 2023 Earnings Call Transcript

NOV Reports Fourth Quarter and Full Year 2023 Earnings

Feb 1, 2024, 5:30 PM EST - 1 year ago

NOV Reports Fourth Quarter and Full Year 2023 Earnings

NOV Inc. (NOV) Q3 2023 Earnings Call Transcript

Oct 27, 2023, 12:37 PM EDT - 2 years ago

NOV Inc. (NOV) Q3 2023 Earnings Call Transcript

NOV Reports Third Quarter 2023 Earnings

Oct 26, 2023, 5:00 PM EDT - 2 years ago

NOV Reports Third Quarter 2023 Earnings

NOV Announces Third Quarter 2023 Earnings Conference Call

Sep 12, 2023, 11:48 AM EDT - 2 years ago

NOV Announces Third Quarter 2023 Earnings Conference Call

Selling Time? Oil, Inflation, Debt Concerns And A T-Bill Portfolio

Aug 15, 2023, 11:00 AM EDT - 2 years ago

Selling Time? Oil, Inflation, Debt Concerns And A T-Bill Portfolio

BBSA BIL BILS DIA EDV EGF EWJ

NOV Inc. (NOV) Q2 2023 Earnings Call Transcript

Jul 27, 2023, 3:44 PM EDT - 2 years ago

NOV Inc. (NOV) Q2 2023 Earnings Call Transcript

NOV Reports Second Quarter 2023 Earnings

Jul 26, 2023, 5:00 PM EDT - 2 years ago

NOV Reports Second Quarter 2023 Earnings

NOV Announces Second Quarter 2023 Earnings Conference Call

Jun 13, 2023, 6:00 PM EDT - 2 years ago

NOV Announces Second Quarter 2023 Earnings Conference Call

INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against NOV Inc. and Encourages Investors with Losses to Contact the Firm

May 3, 2023, 9:30 AM EDT - 2 years ago

INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against NOV Inc. and Encourages Investors with Losses to Contact the Firm

NOV Inc. (NOV) Q1 2023 Earnings Call Transcript

Apr 27, 2023, 4:20 PM EDT - 2 years ago

NOV Inc. (NOV) Q1 2023 Earnings Call Transcript

NOV Reports First Quarter 2023 Earnings

Apr 26, 2023, 5:00 PM EDT - 2 years ago

NOV Reports First Quarter 2023 Earnings

NOV: 2023 Off To A Bad Start

Mar 27, 2023, 5:43 PM EDT - 2 years ago

NOV: 2023 Off To A Bad Start

HeidiNorris9100
HeidiNorris9100 Oct. 23 at 9:01 PM
High-conviction cluster — risk-defined entries only! Portfolio: $META $NOV $BF.B $OXY $ZM Why this cluster: Sector strength aligning with positive sentiment; disciplined entries and stops recommended. META shows relative strength; NOV is base-building; BF.B is a stealth accumulator; OXY offers sector exposure; ZM provides stability. Execution: Plan: small starter position, scale with a confirmed trend; respect risk. #RiskManaged #TopPicks Source:https://stocktwits.com/GaryBrown7417/message/632828520
0 · Reply
RodneyOwens7668
RodneyOwens7668 Oct. 23 at 7:28 PM
High-conviction cluster — risk-defined entries only! Portfolio: $XOM $NVDA $MRK $NOV $LLY Why this cluster: Accumulation noted, range tightening, and cross-sector flow suggests rotation into these names. XOM shows relative strength; NVDA is base-building; MRK is a stealth accumulator; NOV offers sector exposure; LLY provides stability. Execution: Plan: small starter position, scale with a confirmed trend; respect risk. #TradeSetup #Watchlist Source:https://stocktwits.com/VeronicaWarren8662/message/632828887
0 · Reply
Nosecandy_Bear
Nosecandy_Bear Oct. 23 at 6:01 PM
$COST $FDX $NOV $RIVN $T
0 · Reply
ZoeCordova1371
ZoeCordova1371 Oct. 23 at 4:54 PM
Hot setup alert — potential multi-leg move incoming! Portfolio: $LOW $TMUS $AMD $NOV $ORCL Why this cluster: Clean technical bases with improving relative strength; catalysts may trigger a rapid move. LOW shows relative strength; TMUS is base-building; AMD is a stealth accumulator; NOV offers sector exposure; ORCL provides stability. Execution: Watch: monitor news flow and intraday volume for confirmation before heavy sizing. #RiskManaged #TopPicks Source: https://stocktwits.com/GloriaCabrera2156/message/632828656
0 · Reply
CynthiaShepherd1804
CynthiaShepherd1804 Oct. 23 at 4:33 PM
Tape is smoking — catalysts near, volume rising! Portfolio: $NOV $T $FDX $RIVN $COST Why this cluster: Accumulation noted, range tightening, and cross-sector flow suggests rotation into these names. NOV shows relative strength; T is base-building; FDX is a stealth accumulator; RIVN offers sector exposure; COST provides stability. Execution: Execution: define stop levels, use partial profit-taking on initial leg. #MarketPulse #Technical Source: https://stocktwits.com/BrianWatson9291/message/632825018
1 · Reply
ZacksResearch
ZacksResearch Oct. 21 at 6:30 PM
$NOV earnings on deck — and expectations aren’t looking great. Revenue and profit forecasts are signaling declines as softer drilling demand pressures the outlook. Full pre-earnings breakdown here 👉 https://www.zacks.com/stock/news/2773412/factors-you-need-to-know-ahead-of-novs-q3-earnings-release?cid=sm-stocktwits-2-2773412-teaser-16993&ADID=SYND_STOCKTWITS_TWEET_2_2773412_TEASER_16993
0 · Reply
ZacksResearch
ZacksResearch Oct. 21 at 5:30 PM
$NOV Q3 2025 earnings preview — will it disappoint again? 🤔 ⚠️ Expected 27.3% YoY EPS decline for Q3 2025 📉 Revenue forecasted to drop 2.4% from the year-ago period 🛢️ Slowdown in global drilling activity Full analysis here 👉 https://www.zacks.com/stock/news/2773412/factors-you-need-to-know-ahead-of-novs-q3-earnings-release?cid=sm-stocktwits-2-2773412-body-16980&ADID=SYND_STOCKTWITS_TWEET_2_2773412_BODY_16980
0 · Reply
mktxogzqw
mktxogzqw Oct. 18 at 5:18 AM
?? Hot setup alert — potential multi-leg move incoming! ???? ?? Portfolio: $VZ $NOV $IBM $DUK $CAT ?? Why this cluster: Sector strength aligning with positive sentiment; disciplined entries and stops recommended. VZ shows relative strength; NOV is base-building; IBM is a stealth accumulator; DUK offers sector exposure; CAT provides stability. ?? Execution: Watch: monitor news flow and intraday volume for confirmation before heavy sizing. ?? ???? #RiskManaged #TopPicks ???? ?? Source: https://stocktwits.com/RachelWilkerson7204/message/632828552
0 · Reply
DividendDaddyDK
DividendDaddyDK Oct. 16 at 11:11 PM
$NOV are you talking to the man in the mirror?
1 · Reply
ianvestor
ianvestor Oct. 16 at 10:47 PM
$NOV The CEO stepped down 5 months ago you fucking clown.
0 · Reply
DeepValueFinders
DeepValueFinders Oct. 16 at 10:33 PM
$NOV THis guy apparently cant read the news. https://www.fiercepharma.com/pharma/novo-part-ways-longtime-ceo-lars-fruergaard-jorgensen-citing-weight-market-pressures
2 · Reply
SuperGreenToday
SuperGreenToday Oct. 10 at 2:24 AM
$NOV Share Price: $13.15 Contract Selected: Feb 20, 2026 $15 Calls Buy Zone: $0.51 – $0.63 Target Zone: $0.93 – $1.14 Potential Upside: 72% ROI Time to Expiration: 133 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
_CircuitBreaker
_CircuitBreaker Oct. 9 at 11:42 PM
Keep a close watch on CMCT! $NOV $FNV $KRUS $FINV ||
0 · Reply
NeverBearTrader2025
NeverBearTrader2025 Oct. 9 at 4:01 PM
$ALT I wonder why $NOV went after $AKRO instead of $ALT.
0 · Reply
JarvisFlow
JarvisFlow Oct. 8 at 6:39 PM
Citigroup has adjusted their stance on NOV ( $NOV ), setting the rating to Neutral with a target price of 13 → 14.
0 · Reply
MachineLeverage
MachineLeverage Oct. 5 at 2:06 PM
$NOV Energy services strength. Oil price correlation. Breaking above resistance. Volume expansion confirms accumulation.
0 · Reply
clan
clan Sep. 30 at 6:46 PM
$MNKD $GSK $NOV $TAK $MRK This re-manufactured Clofazimine in inhalation form(s) is going to be HUGE for MannKind! Oct. 2025 publication in the Journal Of Pharmaceutical Sciences -- link --> Pulmonary drug delivery of clofazimine: A route of administration and pharmacokinetics guided repositioning strategy against drug resistant tuberculosis informed by use for other disease indications - ScienceDirect https://share.google/PQ72yMfXnstl0IBax
0 · Reply
clan
clan Sep. 29 at 5:36 PM
$MNKD CLOFAZIMINE (CIS) by Mannkind --------------------------------------------------- Designations: - Phase 3 ICoN-1 international trials • U.S.A. & Japan & Australia & Korea - Fast Tracked by FDA - Orpan Drug - Qualified Infectious Disease Product - Well tolerated - No significant Adverse Events - Localized treatment (lungs) - Improved patient adherence - Indications for arthritis & CANCERs - Current global mkt $2.3B [2023] {even with the adverse events (AEs) caused by other pharmas' current formulations} ...and coming soon..... - - - Clofazimine DPI Partner with $GSK ? $NOV ? $TAK ? Maybe $MRK ?
0 · Reply
im_ichiban
im_ichiban Sep. 28 at 8:25 PM
$DEO Warren Buffet $BRK.A disclosed 10% stake like $UNH? Mr Buffet like dividend king $NOV
1 · Reply
HANR
HANR Sep. 26 at 7:11 PM
$IXHL $RMD $NOV $JAZZ I swear I have never seen a shorter as stupid as you You think a stock drop equals a failed drug That is pure ignorance The market is manipulated by whales while the only truth is written in the clinical data The drug showed 83% efficacy numbers you or a hundred like you cannot argue with If your shallow brain believes share price down equals drug does not work then you do not belong here you belong reading fairy tales Get ready to witness the biggest slap in your life when the FDA and a big acquirer prove you are nothing but a dumb crushed short with zero value
1 · Reply
va4f6
va4f6 Sep. 26 at 6:25 PM
$IXHL $RMD $NOV $JAZZ
0 · Reply
va4f6
va4f6 Sep. 26 at 5:43 PM
$IXHL So $IXHL REPOSA Advisory Board has THREE Big Pharma doctors from $RMD $NOV $JAZZ each have their TOP (OSA) Sleep Apnea doctors on the $IXHL REPOSA Advisory Board for a massive reason! REPOSA Phase 2 results were outstanding with NO SIDE EFFECTS!! Doctor Williams from $NOV has a incentive package if REPOSA (pill form therapy) is bought out for $5 Billion Dollars and an even larger incentive package if REPOSA is bought out for $10 Billion Dollars!!! NOW lets discuss the $IXHL BOD's cancelling 347M Class A Warrants AND right after initiating a 20M share buyback SPELLS BIG PHARMA PARTNERSHIP/BUYOUT COMING!! No way BOD's cancelled and paid off all future debt & dilution and initiate a buyback without a Big Pharma DEAL FINALIZED!! Writings on the wall!!
0 · Reply